Specifically, HIF-1α, VEGF, and CA-IX exhibited a remarkably similar distribution in GBM cases [32] (Table 4); however, HIF-1α and VEGF immunoreactivity levels were higher compared to CA-IX levels and were represented with a more diffuse pattern [60] (Table 4). This evidence concerns the gene VEGFA and glioblastoma.